Maurten funding news – Gothenburg-based Maurten Secures €20 Million in Funding
Jul 22, 2024 | By Team SR
Maurten, a leading global sports nutrition company, secures €20 million in funding led by international growth equity fund IRIS Ventures, which specialises in identifying disruptive next-generation consumer propositions. The round also had participation from existing investors, including CEO of Stena Sphere, Dan Sten Olsson.
SUMMARY
- Maurten, a leading global sports nutrition company, secures €20 million in funding.
- Maurten was established in 2015, and by the process of encasing high amounts of carbohydrates in hydrogels, we were able to make sports fuels more tolerable.
The goal of the Maurten sports fuel ecosystem is to find solutions for the real issues limiting athletic performance. Athletes are able to reconsider the boundaries of carbohydrate feeding because to the brand's patented hydrogel technology, which is utilised in its drink mixes, gels, and ground-breaking Maurten Bicarb System.
Read Also - LioniX International funding news – Enschede-based LioniX International Raises €1.5Million in bridge Funding
The performances are the evidence. World records, gold medals, and world champions are examples of exceptional accomplishments that have redefined human capability globally, rather than just amateur personal bests.
RECOMMENDED FOR YOU
[Funding alert] Munich-based Mindfuel Secures €3.75 Million in Seed Funding
Team SR
Mar 15, 2024
Olof Sköld, Maurten Founder and CEO said, “It’s an important moment that strengthens the diversity of our board, I have no doubt that accessing the expertise and network of female-founded Iris Ventures, and their deep understanding of the sports culture scene, will greatly benefit our ambitions to expand the reach of our innovations — across new markets and industries.”
By making significant investments in research-driven development, it makes sure that innovative solutions and product advancements are founded on reliable findings, questioning the status quo when required. Maurten integrates athlete feedback from real-world scenarios with that science-led approach to keep ahead of the rapidly evolving endurance landscape.
This dedication makes it possible for a vision to look for options outside of athletics. The Swedish company currently has two major goals: expanding female-specific fueling research and investigating how Hydrogel Technology could help the medical field. The impact of IRIS Ventures will contribute to this expansion's acceleration.
Montse Suarez, Founder and Managing Partner of IRIS Ventures, commented: “Maurten is a game changer and has, from the outset, redefined athletic performance through world class innovation in the sports nutrition category, seamlessly marrying product excellence with brand uniqueness and edge. The company consistently delivers on their ambitious plans and we are thrilled to join forces with Olof and team.”
Florian Wojewodzki, Partner of IRIS Ventures, added: “Fueling is so mission-critical to performance, that elite endurance athletes are incredibly discerning with what they consume. Credibility is vital. Maurten’s long and growing list of professional athletes is testament to the efficacy of its products and uncompromising focus on innovation. In this context, we are extremely excited to be partnering with Maurten and look forward to supporting them in this next phase of growth.”
About Maurten
Maurten was established in 2015, and by the process of encasing high amounts of carbohydrates in hydrogels, we were able to make sports fuels more tolerable. After our all-natural sports fuels gained popularity, several of the top runners in the globe began utilising our goods a year later. A patent for the technology is pending.